• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

跨膜结构域附近的一个额外半胱氨酸会诱导p185neu和p185neu的不同交联。

An extra cysteine proximal to the transmembrane domain induces differential cross-linking of p185neu and p185neu.

作者信息

Cao H, Bangalore L, Dompé C, Bormann B J, Stern D F

机构信息

Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06510.

出版信息

J Biol Chem. 1992 Oct 5;267(28):20489-92.

PMID:1356980
Abstract

The neu proto-oncogene encodes a receptor tyrosine kinase (p185) that is closely related to the epidermal growth factor receptor. It has been proposed that receptor tyrosine kinases are activated through oligomerization. Because this clustering model predicts that oligomerization of receptors is sufficient to activate them, we determined if p185 can be activated by introducing an extra cysteine proximal to the transmembrane domain. This should induce inter-receptor disulfide bonding and, according to the clustering model, activate the receptor. This amino acid substitution enhanced recovery of both normal and transforming neu proteins as dimers, with normal p185 recovered predominantly as monomers and transforming p185* as dimers. However, the cysteine substitution did not affect the transforming activity of the two proteins.

摘要

神经原癌基因编码一种受体酪氨酸激酶(p185),它与表皮生长因子受体密切相关。有人提出受体酪氨酸激酶通过寡聚化被激活。由于这种聚集模型预测受体的寡聚化足以激活它们,我们通过在跨膜结构域附近引入一个额外的半胱氨酸来确定p185是否可以被激活。这应该会诱导受体间二硫键的形成,并且根据聚集模型,激活受体。这种氨基酸取代增强了正常和转化型神经原蛋白作为二聚体的回收率,正常的p185主要以单体形式回收,而转化型p185*以二聚体形式回收。然而,半胱氨酸取代并不影响这两种蛋白的转化活性。

相似文献

1
An extra cysteine proximal to the transmembrane domain induces differential cross-linking of p185neu and p185neu.跨膜结构域附近的一个额外半胱氨酸会诱导p185neu和p185neu的不同交联。
J Biol Chem. 1992 Oct 5;267(28):20489-92.
2
A subdomain in the transmembrane domain is necessary for p185neu* activation.跨膜结构域中的一个亚结构域对于p185neu*激活是必需的。
EMBO J. 1992 Mar;11(3):923-32. doi: 10.1002/j.1460-2075.1992.tb05131.x.
3
p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity.p185是神经原癌基因的一种产物,是一种与酪氨酸激酶活性相关的类受体蛋白。
Mol Cell Biol. 1986 May;6(5):1729-40. doi: 10.1128/mcb.6.5.1729-1740.1986.
4
Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene.与活化的neu癌基因编码的蛋白质相关的酪氨酸激酶活性增加。
Proc Natl Acad Sci U S A. 1988 Aug;85(15):5394-8. doi: 10.1073/pnas.85.15.5394.
5
Oncogenic activation of p185neu stimulates tyrosine phosphorylation in vivo.p185neu的致癌激活在体内刺激酪氨酸磷酸化。
Mol Cell Biol. 1988 Sep;8(9):3969-73. doi: 10.1128/mcb.8.9.3969-3973.1988.
6
Biochemical comparisons of the normal and oncogenic forms of insect cell-expressed neu tyrosine kinases.昆虫细胞表达的neu酪氨酸激酶正常形式与致癌形式的生化比较。
J Biol Chem. 1992 Jul 15;267(20):13851-6.
7
An oncogenic point mutation confers high affinity ligand binding to the neu receptor. Implications for the generation of site heterogeneity.一种致癌点突变使神经受体具有高亲和力配体结合能力。对位点异质性产生的影响。
J Biol Chem. 1992 Aug 25;267(24):17304-13.
8
A point mutation in the neu oncogene mimics ligand induction of receptor aggregation.neu原癌基因中的一个点突变模拟了配体诱导的受体聚集。
Nature. 1989 May 18;339(6221):230-1. doi: 10.1038/339230a0.
9
A 25 kDa polypeptide is the ligand for p185neu and is secreted by activated macrophages.
Oncogene. 1991 Dec;6(12):2187-96.
10
Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.表皮生长因子诱导的磷酸化过程改变致癌性和细胞neu(NGL)基因产物。
Proc Natl Acad Sci U S A. 1988 Aug;85(15):5389-93. doi: 10.1073/pnas.85.15.5389.

引用本文的文献

1
Membrane receptor activation mechanisms and transmembrane peptide tools to elucidate them.膜受体激活机制和跨膜肽工具来阐明它们。
J Biol Chem. 2020 Feb 14;295(7):1792-1814. doi: 10.1074/jbc.REV119.009457. Epub 2019 Dec 25.
2
Dimerization of the cellular prion protein inhibits propagation of scrapie prions.朊病毒蛋白二聚体抑制瘙痒病朊病毒的传播。
J Biol Chem. 2018 May 25;293(21):8020-8031. doi: 10.1074/jbc.RA117.000990. Epub 2018 Apr 10.
3
How IGF-1 activates its receptor.胰岛素样生长因子-1(IGF-1)如何激活其受体。
Elife. 2014 Sep 25;3:e03772. doi: 10.7554/eLife.03772.
4
Transmembrane helix-helix interactions involved in ErbB receptor signaling.涉及 ErbB 受体信号转导的跨膜螺旋-螺旋相互作用。
Cell Adh Migr. 2010 Apr-Jun;4(2):299-312. doi: 10.4161/cam.4.2.11191. Epub 2010 Apr 13.
5
Stress-protective signalling of prion protein is corrupted by scrapie prions.朊病毒蛋白的应激保护信号传导被羊瘙痒病朊病毒破坏。
EMBO J. 2008 Jul 23;27(14):1974-84. doi: 10.1038/emboj.2008.122. Epub 2008 Jun 19.
6
HER2 therapy. HER2 (ERBB2): functional diversity from structurally conserved building blocks.HER2疗法。HER2(ERBB2):结构保守组件的功能多样性。
Breast Cancer Res. 2007;9(1):202. doi: 10.1186/bcr1633.
7
The transmembrane domain of Neu in a lipid bilayer: molecular dynamics simulations.Neu在脂质双分子层中的跨膜结构域:分子动力学模拟
Eur Biophys J. 2004 Nov;33(7):596-610. doi: 10.1007/s00249-004-0407-2. Epub 2004 Jun 9.
8
Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers.表皮生长因子受体(ErbB)的可控二聚化作用为同型二聚体和异型二聚体的差异信号传导提供了证据。
Mol Cell Biol. 1999 Oct;19(10):6845-57. doi: 10.1128/MCB.19.10.6845.
9
Activation of Neu (ErbB-2) mediated by disulfide bond-induced dimerization reveals a receptor tyrosine kinase dimer interface.由二硫键诱导二聚化介导的Neu(ErbB-2)激活揭示了一种受体酪氨酸激酶二聚体界面。
Mol Cell Biol. 1998 Sep;18(9):5371-9. doi: 10.1128/MCB.18.9.5371.
10
Mutations affecting conserved cysteine residues within the extracellular domain of Neu promote receptor dimerization and activation.影响Neu细胞外结构域内保守半胱氨酸残基的突变会促进受体二聚化和激活。
Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):8878-83. doi: 10.1073/pnas.93.17.8878.